THE RELATIONSHIP OF THE NUMBER OF NEUTROFIL LYMPHOCYTE RATIO WITH THE PICTURE OF COLITIS
Colitis is an acute or chronic inflammation of the colon. The gold standard for diagnosis and monitoring of disease activity in colitis patients is endoscopy combined with pathology biopsy. However, endoscopy has disadvantages related to invasiveness, cost, and feasibility of use for long-term follow-up. The neutrophil-lymphocyte ratio is a simple biomarker that can serve as a useful biomarker for diagnosing and predicting mucosal inflammation in colitis. This study aims to determine whether there is an influence between the number of neutrophil-lymphocyte ratios and the appearance of colitis. This research is a cross-sectional observational analytical research. In this study, 44 medical record data were used. A total of 44 colitis medical record data for the 2022-2023 period were collected. The largest age group is 61-70 years with 11 people (25%), based on the gender group the largest is male with 30 people (68.2%), and based on histopathology the largest is 25 (56.8%) patients. who suffers from chronic colitis. However, in the study, there was no relationship between the neutrophil-lymphocyte ratio and the appearance of colitis, P = 0.22 (P value> 0.05) and the Prevalence Ratio 95% CI 1,436 (0,832-2,476). Based on the results of this study, the majority of patients are male, based on the patient's age, the majority is between 61-70 years, and based on the histopathology picture, the majority is chronic colitis. However, in the study, there was no relationship between the neutrophil-lymphocyte ratio and the appearance of colitis, P = 0.22 (P value > 0.05), and the 95% Prevalence Ratio was 1,436 (0,832-2,476).
Blumenstein, I., & Sonnenberg, E. (2023). Sex- and gender-related differences in inflammatory bowel diseases. Frontiers in Gastroenterology, 2. https://doi.org/10.3389/fgstr.2023.1199687
Buonacera, A., Stancanelli, B., Colaci, M., & Malatino, L. (2022). Neutrophil to Lymphocyte Ratio: An Emerging Marker of the Relationships between the Immune System and Diseases. International Journal of Molecular Sciences, 23(7), 3636. https://doi.org/10.3390/ijms23073636
Citra, I., Tambunan, R. T. H., & Pakpahan, E. A. (2022). Hubungan Antara Nilai Rasio Neutrofil-Limfosit Dengan Terjadinya Infeksi Covid-19 Di Rumah Sakit Putri Hijau Medan Periode 2020. Kedokteran Methodist, 15.
Demir, A. K., Demirtas, A., Kaya, S. U., Tastan, I., Butun, I., Sagcan, M., Sahin, S., Tasliyurt, T., & Yilmaz, A. (2015). The relationship between the neutrophil–lymphocyte ratio and disease activity in patients with ulcerative colitis. The Kaohsiung Journal of Medical Sciences, 31(11), 585–590. https://doi.org/10.1016/j.kjms.2015.10.001
Fu, W., Fu, H., Ye, W., Han, Y., Liu, X., Zhu, S., Li, H., Tang, R., & Wang, Q. (2021). Peripheral blood neutrophil-to-lymphocyte ratio in inflammatory bowel disease and disease activity: A meta-analysis. International Immunopharmacology, 101, 108235. https://doi.org/10.1016/j.intimp.2021.108235
Huang, Z., Fu, Z., Huang, W., & Huang, K. (2020). Prognostic value of neutrophil-to-lymphocyte ratio in sepsis: A meta-analysis. The American Journal of Emergency Medicine, 38(3), 641–647. https://doi.org/10.1016/j.ajem.2019.10.023
Jeong, Y., Jeon, S. R., Kim, H. G., Moon, J. R., Lee, T. H., Jang, J. Y., Cho, J.-H., Park, J. S., Park, H., Lee, K., Kim, J.-O., Lee, J. S., Ko, B. M., & Park, S. (2021). The role of platelet to lymphocyte ratio and neutrophil to lymphocyte ratio in ulcerative colitis. Intestinal Research, 19(1), 62–70. https://doi.org/10.5217/ir.2019.09156
Langley, B. O., Guedry, S. E., Goldenberg, J. Z., Hanes, D. A., Beardsley, J. A., & Ryan, J. J. (2021). Inflammatory Bowel Disease and Neutrophil–Lymphocyte Ratio: A Systematic Scoping Review. Journal of Clinical Medicine, 10(18), 4219. https://doi.org/10.3390/jcm10184219
Ma, L., Pang, X., Ji, G., Ma, X., Li, J., Chang, Y., & Ma, C. (2021). Application of the neutrophil to lymphocyte ratio in the diagnosis and activity determination of ulcerative colitis. Medicine, 100(42), e27551. https://doi.org/10.1097/MD.0000000000027551
Nadya Wulandari Alshant, Ummi Maimunah, & Etty Hary Kusumastuti. (2022). Studi Profil Histopatologi Pasien Kolitis Di Rsud Dr. Soetomo Surabaya. Jurnal Ilmiah Indonesia, 7.
Nizam Oesman. (2014). Buku Ajar Ilmu Penyakit Dalam (A. F. S. Siti Setiati, Idrus Alwi, Aru W, Marcellus Simadbrata K, Bambang Setiyohadi (ed.); II). InternaPublishing.
Okba, A. M., Amin, M. M., Abdelmoaty, A. S., Ebada, H. E., Kamel, A. H., Allam, A. S., & Sobhy, O. M. (2019). Neutrophil/lymphocyte ratio and lymphocyte/monocyte ratio in ulcerative colitis as non-invasive biomarkers of disease activity and severity. Autoimmunity Highlights, 10(1), 4. https://doi.org/10.1186/s13317-019-0114-8
Sunata, K. W., Wibowo, A. A., Oktaviyanti, I. K., Budiwinata, W., & Rosida, L. (2023). Hubungan Derajat Displasia Dengan Jumlah Sel Goblet Pada Gambaran Histopatologi Kolitis Di Rsud Ulin Banjarmasin Pada Tahun 2020-2022. Jurnal Mahasiswa Pendidikan Dokter, 6.
Ungaro, R., Mehandru, S., Allen, P. B., Peyrin-Biroulet, L., & Colombel, J.-F. (2017). Ulcerative colitis. The Lancet, 389(10080), 1756–1770. https://doi.org/10.1016/S0140-6736(16)32126-2
Van Eyken, P., Gerosa, C., Fanni, D., & Ambu, R. (2014). Infections. In Colitis (pp. 81–91). Springer International Publishing. https://doi.org/10.1007/978-3-319-08028-4_5
Yoon, H.-Y., Kim, H.-N., Lee, S. H., Kim, S. J., Chang, Y., Ryu, S., Shin, H., Kim, H.-L., & Lee, J. H. (2018). Association between Neutrophil-to-Lymphocyte Ratio and Gut Microbiota in a Large Population: a Retrospective Cross-Sectional Study. Scientific Reports, 8(1), 16031. https://doi.org/10.1038/s41598-018-34398-4
Zhang, M., Lv, H., Yang, H., Zhang, H., Bai, X., & Qian, J. (2023). Elderly Patients with Moderate-To-Severe Ulcerative Colitis Are More Likely to Have Treatment Failure and Adverse Outcome. Gerontology, 69(2), 119–129. https://doi.org/10.1159/000522569
Copyright (c) 2024 Jurnal Impresi Indonesia

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-ShareAlike 4.0 International (CC-BY-SA). that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.





